References for Personalizing Hormone Replacement Therapy
By Jyotsna Sahni MD
Vol. 4, Issue 2
Pp. 35 - 38
1. Writing Group for the Women's Health Initiative Investigator," Risks and benefits of estrogen plus progestin in healthy postmenopausal women." JAMA 2002; 288: 321-333.
2. Hulley, S. et al. Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II). JAMA. 2002;288:58-64.
3. Ibid., WHI.
4. Bradlow, H., et al., "2-hydroxy estrogen" the 'good' estrogen." J Endocriol 1996; 150 (suppl): S259-265.
5. Bland, J., "Nutritional endocrinology: the estrogen-testosterone-progesterone connection to hypothalamus, pituitary, adrenal, thyroid and endocrine pancreas function," Breakthrough Approaches for Improving Adrenal and Thyroid Function. Gig Harbor: Metagenics, Inc., 2002, p.131-132.
6. Genova Diagnostic Labs
7. Arnot, B. The Breast Cancer Prevention Diet. New York: Little Brown and company, 1998; p.93.
8. Chen, Y., The equine estrogen metabolite 4-hydroxyequilenin causes DNA single-stranded breaks and oxidation of DNA bases in vitro." Chem Res Toxicol 1998; 11:1105-111.
9. Lemon, H., et al., "Pathophysiologic considerations in the treatment of menopausal symptoms with estrogens: the role of estriol in the prevention of mammary carcinoma." ACTA Endocrinol 1980; 233 (suppl): 17-27.
|